Thymol

Thymol

SCHEMBL357328

COC.Cc1ccc(C(C)C)c(O)c1

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.88
TRPA1 O75762 2/20 0.88
CHRM1 P11229 1/20 0.88
SLC6A2 P23975 1/20 0.88
ADRA1A P35348 1/20 0.88
HTR2B P41595 1/20 0.88
SRC P12931 1/20 0.47
IDO1 P14902 1/20 0.45
TDO2 P48775 1/20 0.45
GABRA1 P14867 1/20 0.45
GABRB2 P47870 1/20 0.45
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
TP53 P04637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thymol SCHEMBL429155 1.00 LMNA (0.88) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL29579824 0.94 LMNA (1.00) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL30332213 0.94 LMNA (1.00) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL1867982 0.94 LMNA (1.00) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL22165 0.94 LMNA (1.00) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL23932298 0.91 LMNA (0.95) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL8506977 0.91 LMNA (0.95) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL4729745 0.91 LMNA (0.95) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL7074408 0.91 LMNA (0.95) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL1668335 0.91 LMNA (0.95) LMNATRPA1CHRM1SLC6A2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119424273-A Skin care composition, preparation method and application thereof 稳健医疗用品股份有限公司 2025-02-14 CN claimed
EP-4096618-B1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2025-01-29 EP claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 EP claimed
US-20240050337-A1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2024-02-15 US claimed
CN-116490160-A A mixture containing 1, 2-alkanediol 西姆莱斯股份公司 2023-07-25 CN claimed
CN-115901974-A Detection method of nine-medicinal-material volatile oil 山东新时代药业有限公司 2023-04-04 CN claimed
CN-115901975-A Detection method of radix bupleuri volatile oil 山东新时代药业有限公司 2023-04-04 CN claimed
CN-115876906-A Detection method of volatile oil of traditional Chinese medicine composition 山东新时代药业有限公司 2023-03-31 CN claimed
US-20230043872-A1 COMPOSITION FOR LIP PAIN RELIEF AND METHOD OF MAKING WYSCAVER MEGHAN (US) 2023-02-09 US claimed
EP-4096618-A1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2022-12-07 EP claimed
EP-3650012-A1 SOLID COMPOSITION COMPRISING IODINE AGENT AND SODIUM CHLORIDE HAVING IMPROVED WATER SOLUBILITY, AND ANTIVIRAL AND ANTIMICROBIAL COMPOSITION FOR EYE, ORAL CAVITY, NASAL CAVITY OR INHALATION CONTAINING AQUEOUS SOLUTION THEREOF Fluchem Ltd (KR) 2020-05-13 EP claimed
CN-110799179-A Solid composition comprising iodine reagent and sodium chloride with improved water solubility and antiviral and antibacterial composition for eye, oral cavity, nasal cavity or inhalation comprising aqueous solution thereof 富陆凯米有限责任公司 2020-02-14 CN claimed
US-9743676-B2 Pesticidal compositions comprising a solid insecticide and an essential oil AirRx Antimicrobial Sciences Inc. (US) 2017-08-29 US claimed
EP-3197507-A1 MALODOR REDUCTION COMPOSITIONS The Procter and Gamble Company (US) 2017-08-02 EP claimed
US-20160316765-A1 PESTICIDAL COMPOSITIONS COMPRISING A SOLID INSECTICIDE AND AN ESSENTIAL OIL AIRRX ANTIMICROBIAL SCIENCES INC (US) 2016-11-03 US claimed
WO-2016176618-A1 PESTICIDAL COMPOSITIONS COMPRISING A SOLID INSECTICIDE AND AN ESSENTIAL OIL AirRx Antimicrobial Sciences Inc. (US) 2016-11-03 WO claimed
WO-2016076690-A1 PHARMACOLOGICAL COMPOSITION OF THYME (ESSENTIAL OIL) EXHIBITING AN ANTIBACTERIAL EFFECT ON THE JP2 CLONE OF AGGREGATIBACTER ACTINOMYCETEMCOMITANS UNIVERSITÉ MOHAMMED V DE RABAT (MA) 2016-05-19 WO claimed
US-20160089464-A1 MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
WO-2016049389-A1 MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
CN-104814041-A Microbial source bactericide for controlling cucumber powdery mildew JILIN ACADEMY OF AGRI SCIENCES 2015-08-05 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240050337-A1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS OR10J3, OR51E2, MAL2 LMNA 3527/4885TRPA1 99/4885CHRM1 1519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.